CD&R, Merck GHI, and McKesson Ventures invest oncology data and informatics company M2Gen

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Three years ago, researchers from Memorial Sloan Kettering Cancer Center published stunning results: For the 5% of rectal cancer patients whose tumors are mismatch-repair deficient, neoadjuvant dostarlimab-gxly (Jemperli) has the makings of a silver bullet.

May 02, 2025

By Jacquelyn Cobb

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

“We stand at the edge of discovery, and on the brink of losing it,” said Patricia M. LoRusso, the 2024-2025 president of the American Association for Cancer Research. “I believe this is the most scientifically promising moment in the history of cancer research.”

May 02, 2025

By Claire Marie Porter

Advancing quality of life in oncology: A journey of compassion and innovation

The recent ASCO guideline update on palliative care for cancer patients represents a significant milestone in our field’s evolution. This evidence-based guidance emphasizes what I’ve advocated throughout my career—that palliative care must be integrated early and concurrently throughout the cancer journey. This holistic approach to cancer care has been my life’s work and passion.

May 02, 2025

By Betty Ferrell

Cancer Policy

AACI letter to NIH’s Bhattacharya opposes centralizing review of CCSG

The Association of American Cancer Institutes sent a letter to NIH Director Jay Bhattacharya expressing concern about the proposed NIH policy change that would centralize all grant reviews to the Center for Scientific Review (The Cancer Letter, March 7, 2025).

May 02, 2025

By Jacquelyn Cobb

Cancer Policy

HHS ordered to cut 35% of spending on contracts

HHS spokesperson Andrew Nixon told NPR that HHS will reduce all contracts by 35%.

May 02, 2025

By Jacquelyn Cobb

Cancer Policy

National Cancer Registrars Association launches campaign to protect U.S. cancer registries

The National Cancer Registrars Association launched an advocacy campaign asking the public to contact their representatives and insist upon the protection of essential public health professionals and adequate funding of cancer prevention and research.

May 02, 2025

By Jacquelyn Cobb

CD&R, Merck GHI, and McKesson Ventures invest oncology data and informatics company M2Gen

YOU MAY BE INTERESTED IN

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

Advancing quality of life in oncology: A journey of compassion and innovation

AACI letter to NIH’s Bhattacharya opposes centralizing review of CCSG

HHS ordered to cut 35% of spending on contracts

National Cancer Registrars Association launches campaign to protect U.S. cancer registries

Renew today!

Subscriber content

Never miss an issue!

Login

CD&R, Merck GHI, and McKesson Ventures invest oncology data and informatics company M2Gen

YOU MAY BE INTERESTED IN

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Bertagnolli: NIH funding cuts are “unprecedented and harmful”AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

Advancing quality of life in oncology: A journey of compassion and innovation

AACI letter to NIH’s Bhattacharya opposes centralizing review of CCSG

HHS ordered to cut 35% of spending on contracts

National Cancer Registrars Association launches campaign to protect U.S. cancer registries

Never miss an issue!

Login

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”